Roth Vision Care

09/22/2026

Most studies have said semaglutide has a higher risk than tirzepatide, especially at maximum dose. Poorly controlled diabetes increases risk as well. More studies are needed.

Ed Gillen, of Dedham, suffers from permanent vision loss he attributes to taking a GLP-1.

07/27/2026

Tap water and contacts do not mix!

04/26/2026

04/18/2026

Reminder not to shower in your contacts!

04/09/2026

The number one cause of corneal ulceration in a healthy population is sleeping in your contact lenses.
Do NOT sleep in your contacts!

04/03/2026

Recall on eyedrops

https://www.accessdata.fda.gov/scripts/ires/?Event=98533

The .gov means it's official.Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

03/19/2026

Ischemic optic nerve strokes linked to GLP-1 use. More studies are needed

Published March 19, 2026 Dose-dependent Risk for Ischemic Optic Neuropathy Found with Semaglutide This GLP-1 drug, in its Wegovy formulation, showed a stronger disproportionality signal, which reflects higher reporting intensity of cases rather than volume. By Staff Semaglutide, in any formulation,....

03/14/2026

New treatment for dry macular degeneration!!

Results:
A total of 148 eyes (100 subjects) with dry AMD were randomized into the study. LIGHTSITE III met the prespecified primary BCVA efficacy endpoint at M21 with a significant difference between treatment groups (p = 0.0036) and a +6.2 letter gain following PBM. At M21, 61.5% of PBM-treated eyes showed ≥5, 23.1% showed ≥10, and 4.4% showed ≥15 letter gains. A favorable safety profile was observed with no signs of phototoxicity. Disease progression to Geographic Atrophy (GA) showed a significant decrease in incidence (Sham, 24.0% vs. PBM, 6.8%; p = 0.007) following PBM treatment at M24. Significant benefit in vision QoL was observed.

Conclusions:
Multiwavelength PBM represents an interventional therapy that restores visual function and has potential disease-modifying effects in intermediate dry AMD.

02/21/2026

New research is challenging our thoughts regarding why children become near sighted.

…

Myopia Study Proposes a New Explanation for Why Near Work and Low Light May Drive Nearsightedness

New York, NY — For years, rising rates of myopia — or nearsightedness — have been widely attributed to increased screen time, especially among children and young adults. But new research from scientists at the SUNY College of Optometry suggests the story may be more complicated — and more human.

In a new study published in Cell Reports, researchers propose that myopia may be driven less by screens themselves and more by a common indoor visual habit: prolonged close-up focus in low-light environments, which limits how much light reaches the retina.

…….

So we may need to tell our kids hold things further back and turn on the lights!

02/05/2026

https://www.instagram.com/p/DUQomJsDLJN/?igsh=MWlzdXUyOHc0cG51NA==